Low-molecular-weight heparin successfully used to treat a nephrotic patient complicated by superior mesenteric vein thrombosis and portal vein thrombosis

Medical Principles and Practice

Volumn 20, Issue 2, 2011, Pages 196-199

  Wang, Yi Chun ^a   Chuang, Feng Rong ^a   Lee, Wen Chin ^a   Chen, Te Chuan ^a   Ko, Sheung Fat ^b   Wang, I Kuan ^c   Lee, Chih Hsiung ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Low molecular weight heparin; Mesenteric vein thrombosis; Nephrotic syndrome; Portal vein thrombosis

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN;

ABDOMINAL PAIN; ADULT; ANAMNESIS; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FIBRINOLYTIC THERAPY; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; LIVER CIRRHOSIS; MALE; MESENTERIC VEIN THROMBOSIS; NEPHROTIC SYNDROME; OUTPATIENT CARE; PERIPHERAL VEIN; PORTAL VEIN THROMBOSIS; PROTEINURIA; SUPERIOR MESENTERIC VEIN THROMBOSIS; TREATMENT RESPONSE; VEIN DILATATION; VENOUS THROMBOEMBOLISM;

ANTIHYPERTENSIVE AGENTS; BIPHENYL COMPOUNDS; GLUCOCORTICOIDS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MESENTERIC ARTERY, SUPERIOR; MIDDLE AGED; NEPHROTIC SYNDROME; PORTAL VEIN; PREDNISOLONE; TETRAZOLES; VENOUS THROMBOSIS;

EID: 79251508051     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319925     Document Type: Article

References (10)

1. Kayali F, Najjar R, Aswad F, Matta F, Stein PD: Venous thromboembolism in patients hospitalized with nephrotic syndrome. Am J Med 2008; 121: 226-230.
2. De Luca M, Dugo M, Arduini R, Liessi G: Acute venous thrombosis of spleno-mesenteric portal axis: an unusual localization of thromboembolism in the nephrotic syndrome. Am J Nephrol 1991; 11: 260-263.
3. Sun L, Xu C: Portal vein thrombosis as the first sign of nephrotic syndrome. Nat Clin Pract Nephrol 2008; 4: 342-345.
4. Al Himali SH, Al Osaimi AM, Dahab ST, Khuroo MS, Al Ashgar HI: Budd-Chiari syndrome: experience at King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. Saudi J Gastroenterol 2003; 9: 11-14.
5. Weitz JI: Low-molecular-weight heparins. N Engl J Med 1997; 337: 688-698.
6. Yang SH, Lee CH, Ko SF, Chen JB, Chung FR, Hsu KT: The successful treatment of renalvein thrombosis by low-molecular-weight heparin in a steroid-sensitive nephrotic patient. Nephrol Dial Transplant 2002; 17: 2017-2019.
7. Wijnhoven TJ, Lensen JF, Rops AL, van der Vlag J, Kolset SO, Bangstad HJ, Pfeffer P, van den Hoven MJ, Berden JH, van den Heuvel LP, van Kuppevelt TH: Aberrant heparan sulfate profile in the human diabetic kidney offers new clues for therapeutic glycomimetics. Am J Kidney Dis 2006; 48: 250-261.
8. Krzossok S, Birck R, Koeppel H, Schnulle P, Waldherr R, van der Woude FJ, Braun C: Treatment of proteinuria with low-molecular-weight heparin after renal transplantation. Transpl Int 2004; 17: 468-472.
9. Van den Hoven MJ, Rops AL, Vlodavsky I, Levidiotis V, Berden JH, van der Vlag J: Heparanase in glomerular diseases. Kidney Int 2007; 72: 543-548.
10. Orth SR, Ritz E: The nephrotic syndrome. N Engl J Med 1998; 338: 1202-1211. (Pubitemid 28180750)